233 related articles for article (PubMed ID: 29446062)
1. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data.
Jappe EC; Kringelum J; Trolle T; Nielsen M
Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062
[TBL] [Abstract][Full Text] [Related]
2. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
Tung CW; Ho SY
Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
[TBL] [Abstract][Full Text] [Related]
3. Improved Prediction of Bovine Leucocyte Antigens (BoLA) Presented Ligands by Use of Mass-Spectrometry-Determined Ligand and in Vitro Binding Data.
Nielsen M; Connelley T; Ternette N
J Proteome Res; 2018 Jan; 17(1):559-567. PubMed ID: 29115832
[TBL] [Abstract][Full Text] [Related]
4. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
[TBL] [Abstract][Full Text] [Related]
5. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
6. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
7. Improved methods for predicting peptide binding affinity to MHC class II molecules.
Jensen KK; Andreatta M; Marcatili P; Buus S; Greenbaum JA; Yan Z; Sette A; Peters B; Nielsen M
Immunology; 2018 Jul; 154(3):394-406. PubMed ID: 29315598
[TBL] [Abstract][Full Text] [Related]
8. Footprints of antigen processing boost MHC class II natural ligand predictions.
Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M
Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001
[TBL] [Abstract][Full Text] [Related]
9. Improved prediction of HLA antigen presentation hotspots: Applications for immunogenicity risk assessment of therapeutic proteins.
Attermann AS; Barra C; Reynisson B; Schultz HS; Leurs U; Lamberth K; Nielsen M
Immunology; 2021 Feb; 162(2):208-219. PubMed ID: 33010039
[TBL] [Abstract][Full Text] [Related]
10. RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles.
Bravi B; Tubiana J; Cocco S; Monasson R; Mora T; Walczak AM
Cell Syst; 2021 Feb; 12(2):195-202.e9. PubMed ID: 33338400
[TBL] [Abstract][Full Text] [Related]
11. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
12. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.
Pedersen LE; Rasmussen M; Harndahl M; Nielsen M; Buus S; Jungersen G
Immunogenetics; 2016 Feb; 68(2):157-65. PubMed ID: 26572135
[TBL] [Abstract][Full Text] [Related]
13. In silico design of MHC class I high binding affinity peptides through motifs activation map.
Xiao Z; Zhang Y; Yu R; Chen Y; Jiang X; Wang Z; Li S
BMC Bioinformatics; 2018 Dec; 19(Suppl 19):516. PubMed ID: 30598069
[TBL] [Abstract][Full Text] [Related]
14. Solving an MHC allele-specific bias in the reported immunopeptidome.
Klatt MG; Mack KN; Bai Y; Aretz ZEH; Nathan LI; Mun SS; Dao T; Scheinberg DA
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897882
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex linked databases and prediction tools for designing vaccines.
Singh SP; Mishra BN
Hum Immunol; 2016 Mar; 77(3):295-306. PubMed ID: 26585361
[TBL] [Abstract][Full Text] [Related]
16. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
17. Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design.
Apostolopoulos V; McKenzie IF; Wilson IA
Front Biosci; 2001 Oct; 6():D1311-20. PubMed ID: 11578952
[TBL] [Abstract][Full Text] [Related]
18. Coupling in silico and in vitro analysis of peptide-MHC binding: a bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes.
Doytchinova IA; Walshe VA; Jones NA; Gloster SE; Borrow P; Flower DR
J Immunol; 2004 Jun; 172(12):7495-502. PubMed ID: 15187128
[TBL] [Abstract][Full Text] [Related]
19. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.
Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M
J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689
[TBL] [Abstract][Full Text] [Related]
20. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome.
Kaabinejadian S; Barra C; Alvarez B; Yari H; Hildebrand WH; Nielsen M
Front Immunol; 2022; 13():835454. PubMed ID: 35154160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
